1. Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia
   Laura Patrussi et al, 2021, Cancers CrossRef
2. Activation of the STAT3/microRNA‐21 pathway participates in angiotensin II‐induced angiogenesis
   Li‐Yuan Chen et al, 2019, Journal of Cellular Physiology CrossRef
3. Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages
   Hao-Yu Chuang et al, 2019, Journal of Clinical Medicine CrossRef
4. Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role
   Alessandro Allegra et al, 2020, Cancers CrossRef
5. The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis
   Yanan Wu et al, 2023, Molecular Diagnosis & Therapy CrossRef